0.57 Vanda Pharmaceuticals Inc (VNDA) Faces Revenue Decline Amid Patent Challenges and Generic ...

News


<< back

Vanda Pharmaceuticals Inc (VNDA) Faces Revenue Decline Amid Patent Challenges and Generic ...
Date: 2024-02-07 [news.yahoo.com]

READ THE FULL NEWS >>
×